Latest news

Filters
September 26, 2023

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony

Read more
September 21, 2023

Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers

Read more
September 6, 2023

Debiopharm joins discussions with international health organisations to fight anti-microbial resistance at the 2023 World AMR Congress

Read more
July 6, 2023

Debiopharm Launches “Oncolifestyle” website in Switzerland for People Living with Cancer

Read more
July 3, 2023

8e Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale

Read more
June 21, 2023

Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical…

Read more
June 1, 2023

Debiopharm Shares Oncology Program Updates at ASCO 2023 for Novel WEE1 Inhibitor, and First-In-Class CA IX Theranostic Approach

Read more
May 30, 2023

Debiopharm Launches Phase 1 Research in Small Cell Lung Cancer with WEE1 inhibitor Debio 0123 to Outsmart DDR

Read more
May 25, 2023

Debiopharm Partners with Genedata to Digitalize Translational Research

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.